English
简体中文
Total: £ 56.28
Published Date: 2025-07-08 | Pages: 155 | Tables: 146 | Medical Care
In 2024, the global market size of Medical Second Opinion was estimated to be worth US$ 6973 million and is forecast to reach approximately US$ 27230 million by 2031 with a CAGR of 21.8% during the forecast period 2025-2031.
Medical Second Opinion Service is the additional consultation taken by the patient after the primary diagnosis. The patient can opt for a medical second opinion if the patient feels dissatisfied with the diagnosis or if there is a need for further validation in case of some serious surgical procedures. There has been an upward surge in medical second opinion services mainly due to financial, health and legal costs involved in the treatment. The increased need for improved diagnosis and treatment planning, reducing the financial cost, and ease of interaction is expected to propel the market growth in the forecast period.
The major players in global Medical Second Opinion market include HCA Hospitals, AXA PPP Healthcare, Royal London Group, etc. The top 3 players occupy about 20% shares of the global market. North America and Europe are main markets, they occupy about 60% of the global market. Hospitals is the main type, with a share about 45%. Cancer is the main application, which holds a share about 25%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Medical Second Opinion, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical Second Opinion.
The Medical Second Opinion market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Medical Second Opinion market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Medical Second Opinion companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
HCA Hospitals
AXA PPP Healthcare
Royal London Group
Helsana Group
Cleveland Clinic
Amradnet
Best Doctors Inc
Inova Care
Toranomon Hospital
Keio University Hospital
Johns Hopkins Medicine
Penn Medicine
Oncology International Pvt. Ltd.
GrandOpinion
London Pain Clinic
Mondial Assistance
Medisense
Medo Asia Sdn. Bhd.
Segment by Type
Hospitals
Medical Second Opinion Providing Companies
Health Insurance Companies
Segment by Application
Cancer
Diabetes
Cardiac Disorders
Neurological Disorders
Ocular Disorders
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Medical Second Opinion in global and regional level.
Chapter 3: Detailed analysis of Medical Second Opinion company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Medical Second Opinion revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Study Coverage
1.1 Medical Second Opinion Product Introduction
1.2 Market by Type
1.2.1 Global Medical Second Opinion Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Hospitals
1.2.3 Medical Second Opinion Providing Companies
1.2.4 Health Insurance Companies
1.3 Market by Application
1.3.1 Global Medical Second Opinion Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Cancer
1.3.3 Diabetes
1.3.4 Cardiac Disorders
1.3.5 Neurological Disorders
1.3.6 Ocular Disorders
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Medical Second Opinion Market Size Estimates and Forecasts
2.2 Medical Second Opinion Market Size by Region: 2024 Versus 2031
2.2.1 Global Medical Second Opinion Revenue by Region: 2020-2025
2.2.2 Global Medical Second Opinion Revenue Forecast by Region (2026-2031)
2.2.3 Global Medical Second Opinion Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Medical Second Opinion Revenue by Type (2020-2031)
3.1.2 Global Medical Second Opinion Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Medical Second Opinion Revenue by Application (2020-2031)
3.2.2 Global Medical Second Opinion Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Hospitals of Medical Second Opinion Revenue Market Share by Application
3.3.2 Medical Second Opinion Providing Companies of Medical Second Opinion Revenue Market Share by Application
3.3.3 Health Insurance Companies of Medical Second Opinion Revenue Market Share by Application
4 Global Medical Second Opinion by Company
4.1 Global Medical Second Opinion Revenue by Company (2020-2025)
4.2 Global Medical Second Opinion Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Medical Second Opinion Companies around the World: Ranking by Revenue
4.3.2 Global Medical Second Opinion Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Medical Second Opinion Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Medical Second Opinion Companies Headquarters & Product Type
4.4.1 Global Medical Second Opinion Companies Headquarters
4.4.2 Date of International Companies Enter into Medical Second Opinion Market
4.4.3 Global Medical Second Opinion Companies Product & Service
4.4.4 Hospitals Revenue Market Share of Medical Second Opinion by Company
4.4.5 Medical Second Opinion Providing Companies Revenue Market Share of Medical Second Opinion by Company
4.4.6 Health Insurance Companies Revenue Market Share of Medical Second Opinion by Company
4.5 Global Medical Second Opinion Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 HCA Hospitals
5.1.1 HCA Hospitals Corporation Information
5.1.2 HCA Hospitals Description, Business Overview
5.1.3 HCA Hospitals Medical Second Opinion Products Offered
5.1.4 HCA Hospitals Medical Second Opinion Revenue and Gross Margin (2020-2025)
5.1.5 HCA Hospitals Medical Second Opinion Revenue by Product in 2024
5.1.6 HCA Hospitals Medical Second Opinion Revenue by Application in 2024
5.1.7 HCA Hospitals Medical Second Opinion Revenue by Geographic Area in 2024
5.1.8 HCA Hospitals Recent Developments
5.2 AXA PPP Healthcare
5.2.1 AXA PPP Healthcare Corporation Information
5.2.2 AXA PPP Healthcare Description, Business Overview
5.2.3 AXA PPP Healthcare Medical Second Opinion Products Offered
5.2.4 AXA PPP Healthcare Medical Second Opinion Revenue and Gross Margin (2020-2025)
5.2.5 AXA PPP Healthcare Medical Second Opinion Revenue by Product in 2024
5.2.6 AXA PPP Healthcare Medical Second Opinion Revenue by Application in 2024
5.2.7 AXA PPP Healthcare Medical Second Opinion Revenue by Geographic Area in 2024
5.2.8 AXA PPP Healthcare Recent Developments
5.3 Royal London Group
5.3.1 Royal London Group Corporation Information
5.3.2 Royal London Group Description, Business Overview
5.3.3 Royal London Group Medical Second Opinion Products Offered
5.3.4 Royal London Group Medical Second Opinion Revenue and Gross Margin (2020-2025)
5.3.5 Royal London Group Medical Second Opinion Revenue by Product in 2024
5.3.6 Royal London Group Medical Second Opinion Revenue by Application in 2024
5.3.7 Royal London Group Medical Second Opinion Revenue by Geographic Area in 2024
5.3.8 Royal London Group Recent Developments
5.4 Helsana Group
5.4.1 Helsana Group Corporation Information
5.4.2 Helsana Group Description, Business Overview
5.4.3 Helsana Group Medical Second Opinion Products Offered
5.4.4 Helsana Group Medical Second Opinion Revenue and Gross Margin (2020-2025)
5.4.5 Helsana Group Medical Second Opinion Revenue by Product in 2024
5.4.6 Helsana Group Medical Second Opinion Revenue by Application in 2024
5.4.7 Helsana Group Medical Second Opinion Revenue by Geographic Area in 2024
5.4.8 Helsana Group Recent Developments
5.5 Cleveland Clinic
5.5.1 Cleveland Clinic Corporation Information
5.5.2 Cleveland Clinic Description, Business Overview
5.5.3 Cleveland Clinic Medical Second Opinion Products Offered
5.5.4 Cleveland Clinic Medical Second Opinion Revenue and Gross Margin (2020-2025)
5.5.5 Cleveland Clinic Medical Second Opinion Revenue by Product in 2024
5.5.6 Cleveland Clinic Medical Second Opinion Revenue by Application in 2024
5.5.7 Cleveland Clinic Medical Second Opinion Revenue by Geographic Area in 2024
5.5.8 Cleveland Clinic Recent Developments
5.6 Amradnet
5.6.1 Amradnet Corporation Information
5.6.2 Amradnet Description, Business Overview
5.6.3 Amradnet Medical Second Opinion Products Offered
5.6.4 Amradnet Medical Second Opinion Revenue and Gross Margin (2020-2025)
5.6.5 Amradnet Medical Second Opinion Revenue by Product in 2024
5.6.6 Amradnet Medical Second Opinion Revenue by Application in 2024
5.6.7 Amradnet Medical Second Opinion Revenue by Geographic Area in 2024
5.6.8 Amradnet Recent Developments
5.7 Best Doctors Inc
5.7.1 Best Doctors Inc Corporation Information
5.7.2 Best Doctors Inc Description, Business Overview
5.7.3 Best Doctors Inc Medical Second Opinion Products Offered
5.7.4 Best Doctors Inc Medical Second Opinion Revenue and Gross Margin (2020-2025)
5.7.5 Best Doctors Inc Medical Second Opinion Revenue by Product in 2024
5.7.6 Best Doctors Inc Medical Second Opinion Revenue by Application in 2024
5.7.7 Best Doctors Inc Medical Second Opinion Revenue by Geographic Area in 2024
5.7.8 Best Doctors Inc Recent Developments
5.8 Inova Care
5.8.1 Inova Care Corporation Information
5.8.2 Inova Care Description, Business Overview
5.8.3 Inova Care Medical Second Opinion Products Offered
5.8.4 Inova Care Medical Second Opinion Revenue and Gross Margin (2020-2025)
5.8.5 Inova Care Medical Second Opinion Revenue by Product in 2024
5.8.6 Inova Care Medical Second Opinion Revenue by Application in 2024
5.8.7 Inova Care Medical Second Opinion Revenue by Geographic Area in 2024
5.8.8 Inova Care Recent Developments
5.9 Toranomon Hospital
5.9.1 Toranomon Hospital Corporation Information
5.9.2 Toranomon Hospital Description, Business Overview
5.9.3 Toranomon Hospital Medical Second Opinion Products Offered
5.9.4 Toranomon Hospital Medical Second Opinion Revenue and Gross Margin (2020-2025)
5.9.5 Toranomon Hospital Medical Second Opinion Revenue by Product in 2024
5.9.6 Toranomon Hospital Medical Second Opinion Revenue by Application in 2024
5.9.7 Toranomon Hospital Medical Second Opinion Revenue by Geographic Area in 2024
5.9.8 Toranomon Hospital Recent Developments
5.10 Keio University Hospital
5.10.1 Keio University Hospital Corporation Information
5.10.2 Keio University Hospital Description, Business Overview
5.10.3 Keio University Hospital Medical Second Opinion Products Offered
5.10.4 Keio University Hospital Medical Second Opinion Revenue and Gross Margin (2020-2025)
5.10.5 Keio University Hospital Medical Second Opinion Revenue by Product in 2024
5.10.6 Keio University Hospital Medical Second Opinion Revenue by Application in 2024
5.10.7 Keio University Hospital Medical Second Opinion Revenue by Geographic Area in 2024
5.10.8 Keio University Hospital Recent Developments
5.11 Johns Hopkins Medicine
5.11.1 Johns Hopkins Medicine Corporation Information
5.11.2 Johns Hopkins Medicine Description, Business Overview
5.11.3 Johns Hopkins Medicine Medical Second Opinion Products Offered
5.11.4 Johns Hopkins Medicine Medical Second Opinion Revenue and Gross Margin (2020-2025)
5.11.5 Johns Hopkins Medicine Medical Second Opinion Revenue by Product in 2024
5.11.6 Johns Hopkins Medicine Medical Second Opinion Revenue by Application in 2024
5.11.7 Johns Hopkins Medicine Medical Second Opinion Revenue by Geographic Area in 2024
5.11.8 Johns Hopkins Medicine Recent Developments
5.12 Penn Medicine
5.12.1 Penn Medicine Corporation Information
5.12.2 Penn Medicine Description, Business Overview
5.12.3 Penn Medicine Medical Second Opinion Products Offered
5.12.4 Penn Medicine Medical Second Opinion Revenue and Gross Margin (2020-2025)
5.12.5 Penn Medicine Medical Second Opinion Revenue by Product in 2024
5.12.6 Penn Medicine Medical Second Opinion Revenue by Application in 2024
5.12.7 Penn Medicine Medical Second Opinion Revenue by Geographic Area in 2024
5.12.8 Penn Medicine Recent Developments
5.13 Oncology International Pvt. Ltd.
5.13.1 Oncology International Pvt. Ltd. Corporation Information
5.13.2 Oncology International Pvt. Ltd. Description, Business Overview
5.13.3 Oncology International Pvt. Ltd. Medical Second Opinion Products Offered
5.13.4 Oncology International Pvt. Ltd. Medical Second Opinion Revenue and Gross Margin (2020-2025)
5.13.5 Oncology International Pvt. Ltd. Medical Second Opinion Revenue by Product in 2024
5.13.6 Oncology International Pvt. Ltd. Medical Second Opinion Revenue by Application in 2024
5.13.7 Oncology International Pvt. Ltd. Medical Second Opinion Revenue by Geographic Area in 2024
5.13.8 Oncology International Pvt. Ltd. Recent Developments
5.14 GrandOpinion
5.14.1 GrandOpinion Corporation Information
5.14.2 GrandOpinion Description, Business Overview
5.14.3 GrandOpinion Medical Second Opinion Products Offered
5.14.4 GrandOpinion Medical Second Opinion Revenue and Gross Margin (2020-2025)
5.14.5 GrandOpinion Medical Second Opinion Revenue by Product in 2024
5.14.6 GrandOpinion Medical Second Opinion Revenue by Application in 2024
5.14.7 GrandOpinion Medical Second Opinion Revenue by Geographic Area in 2024
5.14.8 GrandOpinion Recent Developments
5.15 London Pain Clinic
5.15.1 London Pain Clinic Corporation Information
5.15.2 London Pain Clinic Description, Business Overview
5.15.3 London Pain Clinic Medical Second Opinion Products Offered
5.15.4 London Pain Clinic Medical Second Opinion Revenue and Gross Margin (2020-2025)
5.15.5 London Pain Clinic Medical Second Opinion Revenue by Product in 2024
5.15.6 London Pain Clinic Medical Second Opinion Revenue by Application in 2024
5.15.7 London Pain Clinic Medical Second Opinion Revenue by Geographic Area in 2024
5.15.8 London Pain Clinic Recent Developments
5.16 Mondial Assistance
5.16.1 Mondial Assistance Corporation Information
5.16.2 Mondial Assistance Description, Business Overview
5.16.3 Mondial Assistance Medical Second Opinion Products Offered
5.16.4 Mondial Assistance Medical Second Opinion Revenue and Gross Margin (2020-2025)
5.16.5 Mondial Assistance Medical Second Opinion Revenue by Product in 2024
5.16.6 Mondial Assistance Medical Second Opinion Revenue by Application in 2024
5.16.7 Mondial Assistance Medical Second Opinion Revenue by Geographic Area in 2024
5.16.8 Mondial Assistance Recent Developments
5.17 Medisense
5.17.1 Medisense Corporation Information
5.17.2 Medisense Description, Business Overview
5.17.3 Medisense Medical Second Opinion Products Offered
5.17.4 Medisense Medical Second Opinion Revenue and Gross Margin (2020-2025)
5.17.5 Medisense Medical Second Opinion Revenue by Product in 2024
5.17.6 Medisense Medical Second Opinion Revenue by Application in 2024
5.17.7 Medisense Medical Second Opinion Revenue by Geographic Area in 2024
5.17.8 Medisense Recent Developments
5.18 Medo Asia Sdn. Bhd.
5.18.1 Medo Asia Sdn. Bhd. Corporation Information
5.18.2 Medo Asia Sdn. Bhd. Description, Business Overview
5.18.3 Medo Asia Sdn. Bhd. Medical Second Opinion Products Offered
5.18.4 Medo Asia Sdn. Bhd. Medical Second Opinion Revenue and Gross Margin (2020-2025)
5.18.5 Medo Asia Sdn. Bhd. Medical Second Opinion Revenue by Product in 2024
5.18.6 Medo Asia Sdn. Bhd. Medical Second Opinion Revenue by Application in 2024
5.18.7 Medo Asia Sdn. Bhd. Medical Second Opinion Revenue by Geographic Area in 2024
5.18.8 Medo Asia Sdn. Bhd. Recent Developments
6 North America
6.1 North America Medical Second Opinion Market Size YoY Growth 2020-2031
6.2 North America Medical Second Opinion Market Facts & Figures by Country (2020-2031)
6.3 North America Medical Second Opinion Revenue by Type (2020-2025)
6.4 North America Medical Second Opinion Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Medical Second Opinion Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Medical Second Opinion Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Medical Second Opinion Revenue by Type (2020-2025)
7.4 Asia-Pacific Medical Second Opinion Revenue by Application (2020-2025)
8 Europe
8.1 Europe Medical Second Opinion Market Size YoY Growth 2020-2031
8.2 Europe Medical Second Opinion Market Facts & Figures by Country (2020-2031)
8.3 Europe Medical Second Opinion Revenue by Type (2020-2025)
8.4 Europe Medical Second Opinion Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Medical Second Opinion Market Size YoY Growth 2020-2031
9.2 Latin America Medical Second Opinion Market Facts & Figures by Country (2020-2031)
9.3 Latin America Medical Second Opinion Revenue by Type (2020-2025)
9.4 Latin America Medical Second Opinion Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Medical Second Opinion Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Medical Second Opinion Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Medical Second Opinion Revenue by Type (2020-2025)
10.4 Middle East and Africa Medical Second Opinion Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Medical Second Opinion Supply Chain Analysis
11.2 Medical Second Opinion Key Raw Materials and Upstream Suppliers
11.3 Medical Second Opinion Clients Analysis
11.4 Medical Second Opinion Sales Channel and Sales Model Analysis
11.4.1 Medical Second Opinion Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Medical Second Opinion Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Medical Second Opinion Distributors
12 Medical Second Opinion Market Dynamics
12.1 Medical Second Opinion Industry Trends
12.2 Medical Second Opinion Market Drivers
12.3 Medical Second Opinion Market Challenges
12.4 Medical Second Opinion Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Medical Second Opinion Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Medical Second Opinion Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Medical Second Opinion Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Medical Second Opinion Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Medical Second Opinion Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Medical Second Opinion Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Medical Second Opinion Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Medical Second Opinion Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Medical Second Opinion Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Medical Second Opinion Revenue by Company (2020-2025) & (US$ Million)
Table 11. Medical Second Opinion Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Medical Second Opinion Players by Revenue (US$ Million) in 2024
Table 13. Global Medical Second Opinion Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Medical Second Opinion by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical Second Opinion as of 2024)
Table 15. Global Medical Second Opinion Companies Headquarters
Table 16. Date of International Companies Enter into Medical Second Opinion Market
Table 17. Global Medical Second Opinion Companies Product & Service
Table 18. Global Medical Second Opinion Mergers & Acquisitions, Expansion Plans
Table 19. HCA Hospitals Corporation Information
Table 20. HCA Hospitals Description and Business Overview
Table 21. HCA Hospitals Medical Second Opinion Product
Table 22. HCA Hospitals Medical Second Opinion Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. HCA Hospitals Revenue Proportion of Medical Second Opinion by Product in 2024
Table 24. HCA Hospitals Revenue Proportion of Medical Second Opinion by Application in 2024
Table 25. HCA Hospitals Revenue Proportion of Medical Second Opinion by Geographic Area in 2024
Table 26. HCA Hospitals Recent Developments
Table 27. AXA PPP Healthcare Corporation Information
Table 28. AXA PPP Healthcare Description and Business Overview
Table 29. AXA PPP Healthcare Medical Second Opinion Product
Table 30. AXA PPP Healthcare Medical Second Opinion Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. AXA PPP Healthcare Revenue Proportion of Medical Second Opinion by Product in 2024
Table 32. AXA PPP Healthcare Revenue Proportion of Medical Second Opinion by Application in 2024
Table 33. AXA PPP Healthcare Revenue Proportion of Medical Second Opinion by Geographic Area in 2024
Table 34. AXA PPP Healthcare Recent Developments
Table 35. Royal London Group Corporation Information
Table 36. Royal London Group Description and Business Overview
Table 37. Royal London Group Medical Second Opinion Product
Table 38. Royal London Group Medical Second Opinion Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. Royal London Group Revenue Proportion of Medical Second Opinion by Product in 2024
Table 40. Royal London Group Revenue Proportion of Medical Second Opinion by Application in 2024
Table 41. Royal London Group Revenue Proportion of Medical Second Opinion by Geographic Area in 2024
Table 42. Royal London Group Recent Developments
Table 43. Helsana Group Corporation Information
Table 44. Helsana Group Description and Business Overview
Table 45. Helsana Group Medical Second Opinion Product
Table 46. Helsana Group Medical Second Opinion Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Helsana Group Revenue Proportion of Medical Second Opinion by Product in 2024
Table 48. Helsana Group Revenue Proportion of Medical Second Opinion by Application in 2024
Table 49. Helsana Group Revenue Proportion of Medical Second Opinion by Geographic Area in 2024
Table 50. Helsana Group Recent Developments
Table 51. Cleveland Clinic Corporation Information
Table 52. Cleveland Clinic Description and Business Overview
Table 53. Cleveland Clinic Medical Second Opinion Product
Table 54. Cleveland Clinic Medical Second Opinion Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. Cleveland Clinic Revenue Proportion of Medical Second Opinion by Product in 2024
Table 56. Cleveland Clinic Revenue Proportion of Medical Second Opinion by Application in 2024
Table 57. Cleveland Clinic Revenue Proportion of Medical Second Opinion by Geographic Area in 2024
Table 58. Cleveland Clinic Recent Developments
Table 59. Amradnet Corporation Information
Table 60. Amradnet Description and Business Overview
Table 61. Amradnet Medical Second Opinion Product
Table 62. Amradnet Medical Second Opinion Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. Amradnet Revenue Proportion of Medical Second Opinion by Product in 2024
Table 64. Amradnet Revenue Proportion of Medical Second Opinion by Application in 2024
Table 65. Amradnet Revenue Proportion of Medical Second Opinion by Geographic Area in 2024
Table 66. Amradnet Recent Developments
Table 67. Best Doctors Inc Corporation Information
Table 68. Best Doctors Inc Description and Business Overview
Table 69. Best Doctors Inc Medical Second Opinion Product
Table 70. Best Doctors Inc Medical Second Opinion Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. Best Doctors Inc Revenue Proportion of Medical Second Opinion by Product in 2024
Table 72. Best Doctors Inc Revenue Proportion of Medical Second Opinion by Application in 2024
Table 73. Best Doctors Inc Revenue Proportion of Medical Second Opinion by Geographic Area in 2024
Table 74. Best Doctors Inc Recent Developments
Table 75. Inova Care Corporation Information
Table 76. Inova Care Description and Business Overview
Table 77. Inova Care Medical Second Opinion Product
Table 78. Inova Care Medical Second Opinion Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. Inova Care Revenue Proportion of Medical Second Opinion by Product in 2024
Table 80. Inova Care Revenue Proportion of Medical Second Opinion by Application in 2024
Table 81. Inova Care Revenue Proportion of Medical Second Opinion by Geographic Area in 2024
Table 82. Inova Care Recent Developments
Table 83. Toranomon Hospital Corporation Information
Table 84. Toranomon Hospital Description and Business Overview
Table 85. Toranomon Hospital Medical Second Opinion Product
Table 86. Toranomon Hospital Medical Second Opinion Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. Toranomon Hospital Revenue Proportion of Medical Second Opinion by Product in 2024
Table 88. Toranomon Hospital Revenue Proportion of Medical Second Opinion by Application in 2024
Table 89. Toranomon Hospital Revenue Proportion of Medical Second Opinion by Geographic Area in 2024
Table 90. Toranomon Hospital Recent Developments
Table 91. Keio University Hospital Corporation Information
Table 92. Keio University Hospital Description and Business Overview
Table 93. Keio University Hospital Medical Second Opinion Product
Table 94. Keio University Hospital Medical Second Opinion Revenue (US$ Million) and Gross Margin (2020-2025)
Table 95. Keio University Hospital Revenue Proportion of Medical Second Opinion by Product in 2024
Table 96. Keio University Hospital Revenue Proportion of Medical Second Opinion by Application in 2024
Table 97. Keio University Hospital Revenue Proportion of Medical Second Opinion by Geographic Area in 2024
Table 98. Keio University Hospital Recent Developments
Table 99. Johns Hopkins Medicine Corporation Information
Table 100. Johns Hopkins Medicine Description and Business Overview
Table 101. Johns Hopkins Medicine Medical Second Opinion Product
Table 102. Johns Hopkins Medicine Medical Second Opinion Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Johns Hopkins Medicine Revenue Proportion of Medical Second Opinion by Product in 2024
Table 104. Johns Hopkins Medicine Revenue Proportion of Medical Second Opinion by Application in 2024
Table 105. Johns Hopkins Medicine Revenue Proportion of Medical Second Opinion by Geographic Area in 2024
Table 106. Johns Hopkins Medicine Recent Developments
Table 107. Penn Medicine Corporation Information
Table 108. Penn Medicine Description and Business Overview
Table 109. Penn Medicine Medical Second Opinion Product
Table 110. Penn Medicine Medical Second Opinion Revenue (US$ Million) and Gross Margin (2020-2025)
Table 111. Penn Medicine Revenue Proportion of Medical Second Opinion by Product in 2024
Table 112. Penn Medicine Revenue Proportion of Medical Second Opinion by Application in 2024
Table 113. Penn Medicine Revenue Proportion of Medical Second Opinion by Geographic Area in 2024
Table 114. Penn Medicine Recent Developments
Table 115. Oncology International Pvt. Ltd. Corporation Information
Table 116. Oncology International Pvt. Ltd. Description and Business Overview
Table 117. Oncology International Pvt. Ltd. Medical Second Opinion Product
Table 118. Oncology International Pvt. Ltd. Medical Second Opinion Revenue (US$ Million) and Gross Margin (2020-2025)
Table 119. Oncology International Pvt. Ltd. Revenue Proportion of Medical Second Opinion by Product in 2024
Table 120. Oncology International Pvt. Ltd. Revenue Proportion of Medical Second Opinion by Application in 2024
Table 121. Oncology International Pvt. Ltd. Revenue Proportion of Medical Second Opinion by Geographic Area in 2024
Table 122. Oncology International Pvt. Ltd. Recent Developments
Table 123. GrandOpinion Corporation Information
Table 124. GrandOpinion Description and Business Overview
Table 125. GrandOpinion Medical Second Opinion Product
Table 126. GrandOpinion Medical Second Opinion Revenue (US$ Million) and Gross Margin (2020-2025)
Table 127. GrandOpinion Revenue Proportion of Medical Second Opinion by Product in 2024
Table 128. GrandOpinion Revenue Proportion of Medical Second Opinion by Application in 2024
Table 129. GrandOpinion Revenue Proportion of Medical Second Opinion by Geographic Area in 2024
Table 130. GrandOpinion Recent Developments
Table 131. London Pain Clinic Corporation Information
Table 132. London Pain Clinic Description and Business Overview
Table 133. London Pain Clinic Medical Second Opinion Product
Table 134. London Pain Clinic Medical Second Opinion Revenue (US$ Million) and Gross Margin (2020-2025)
Table 135. London Pain Clinic Revenue Proportion of Medical Second Opinion by Product in 2024
Table 136. London Pain Clinic Revenue Proportion of Medical Second Opinion by Application in 2024
Table 137. London Pain Clinic Revenue Proportion of Medical Second Opinion by Geographic Area in 2024
Table 138. London Pain Clinic Recent Developments
Table 139. Mondial Assistance Corporation Information
Table 140. Mondial Assistance Description and Business Overview
Table 141. Mondial Assistance Medical Second Opinion Product
Table 142. Mondial Assistance Medical Second Opinion Revenue (US$ Million) and Gross Margin (2020-2025)
Table 143. Mondial Assistance Revenue Proportion of Medical Second Opinion by Product in 2024
Table 144. Mondial Assistance Revenue Proportion of Medical Second Opinion by Application in 2024
Table 145. Mondial Assistance Revenue Proportion of Medical Second Opinion by Geographic Area in 2024
Table 146. Mondial Assistance Recent Developments
Table 147. Medisense Corporation Information
Table 148. Medisense Description and Business Overview
Table 149. Medisense Medical Second Opinion Product
Table 150. Medisense Medical Second Opinion Revenue (US$ Million) and Gross Margin (2020-2025)
Table 151. Medisense Revenue Proportion of Medical Second Opinion by Product in 2024
Table 152. Medisense Revenue Proportion of Medical Second Opinion by Application in 2024
Table 153. Medisense Revenue Proportion of Medical Second Opinion by Geographic Area in 2024
Table 154. Medisense Recent Developments
Table 155. Medo Asia Sdn. Bhd. Corporation Information
Table 156. Medo Asia Sdn. Bhd. Description and Business Overview
Table 157. Medo Asia Sdn. Bhd. Medical Second Opinion Product
Table 158. Medo Asia Sdn. Bhd. Medical Second Opinion Revenue (US$ Million) and Gross Margin (2020-2025)
Table 159. Medo Asia Sdn. Bhd. Revenue Proportion of Medical Second Opinion by Product in 2024
Table 160. Medo Asia Sdn. Bhd. Revenue Proportion of Medical Second Opinion by Application in 2024
Table 161. Medo Asia Sdn. Bhd. Revenue Proportion of Medical Second Opinion by Geographic Area in 2024
Table 162. Medo Asia Sdn. Bhd. Recent Developments
Table 163. North America Medical Second Opinion Revenue by Country (2020-2025) & (US$ Million)
Table 164. North America Medical Second Opinion Revenue by Country (2026-2031) & (US$ Million)
Table 165. North America Medical Second Opinion Revenue by Type (2020-2025) & (US$ Million)
Table 166. North America Medical Second Opinion Revenue by Application (2020-2025) & (US$ Million)
Table 167. Asia-Pacific Medical Second Opinion Revenue by Region (2020-2025) & (US$ Million)
Table 168. Asia-Pacific Medical Second Opinion Revenue by Region (2026-2031) & (US$ Million)
Table 169. Asia-Pacific Medical Second Opinion Revenue by Type (2020-2025) & (US$ Million)
Table 170. Asia-Pacific Medical Second Opinion Revenue by Application (2020-2025) & (US$ Million)
Table 171. Europe Medical Second Opinion Revenue by Country (2020-2025) & (US$ Million)
Table 172. Europe Medical Second Opinion Revenue by Country (2026-2031) & (US$ Million)
Table 173. Europe Medical Second Opinion Revenue by Type (2020-2025) & (US$ Million)
Table 174. Europe Medical Second Opinion Revenue by Application (2020-2025) & (US$ Million)
Table 175. Latin America Medical Second Opinion Revenue by Country (2020-2025) & (US$ Million)
Table 176. Latin America Medical Second Opinion Revenue by Country (2026-2031) & (US$ Million)
Table 177. Latin America Medical Second Opinion Revenue by Type (2020-2025) & (US$ Million)
Table 178. Latin America Medical Second Opinion Revenue by Application (2020-2025) & (US$ Million)
Table 179. Middle East and Africa Medical Second Opinion Revenue by Country (2020-2025) & (US$ Million)
Table 180. Middle East and Africa Medical Second Opinion Revenue by Country (2026-2031) & (US$ Million)
Table 181. Middle East and Africa Medical Second Opinion Revenue by Type (2020-2025) & (US$ Million)
Table 182. Middle East and Africa Medical Second Opinion Revenue by Application (2020-2025) & (US$ Million)
Table 183. Medical Second Opinion Key Raw Materials, Industry Status and Trend
Table 184. Medical Second Opinion Key Raw Materials and Upstream Suppliers
Table 185. Medical Second Opinion Clients Status and Trend
Table 186. Medical Second Opinion Typical Clients
Table 187. Medical Second Opinion Distributors
Table 188. Medical Second Opinion Market Trends
Table 189. Medical Second Opinion Market Drivers
Table 190. Medical Second Opinion Market Challenges
Table 191. Medical Second Opinion Market Restraints
Table 192. Research Programs/Design for This Report
Table 193. Key Data Information from Secondary Sources
Table 194. Key Data Information from Primary Sources
List of Figures
Figure 1. Medical Second Opinion Product Picture
Figure 2. Global Medical Second Opinion Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Medical Second Opinion Revenue Market Share by Type in 2024 & 2031
Figure 4. Hospitals Product Picture
Figure 5. Medical Second Opinion Providing Companies Product Picture
Figure 6. Health Insurance Companies Product Picture
Figure 7. Global Medical Second Opinion Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 8. Global Medical Second Opinion Revenue Market Share by Application in 2024 & 2031
Figure 9. Cancer
Figure 10. Diabetes
Figure 11. Cardiac Disorders
Figure 12. Neurological Disorders
Figure 13. Ocular Disorders
Figure 14. Others
Figure 15. Medical Second Opinion Report Years Considered
Figure 16. Global Medical Second Opinion Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Medical Second Opinion Market Size (2020-2031) & (US$ Million)
Figure 18. Global Medical Second Opinion Market Size Market Share by Region: 2024 Versus 2031
Figure 19. Global Medical Second Opinion Revenue Market Share by Region (2020-2031)
Figure 20. Global Medical Second Opinion Revenue Market Share Forecast by Type (2020-2031)
Figure 21. Global Medical Second Opinion Revenue Market Share Forecast by Application (2020-2031)
Figure 22. Hospitals of Medical Second Opinion Revenue Market Share by Application, 2024 VS 2031
Figure 23. Medical Second Opinion Providing Companies of Medical Second Opinion Revenue Market Share by Application, 2024 VS 2031
Figure 24. Health Insurance Companies of Medical Second Opinion Revenue Market Share by Application, 2024 VS 2031
Figure 25. Medical Second Opinion Revenue Share by Company (2024)
Figure 26. Medical Second Opinion Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 27. Hospitals Revenue Proportion by Company in 2024
Figure 28. Medical Second Opinion Providing Companies Revenue Proportion by Company in 2024
Figure 29. Health Insurance Companies Revenue Proportion by Company in 2024
Figure 30. North America Medical Second Opinion Revenue 2020-2031 (US$ Million)
Figure 31. North America Medical Second Opinion Revenue Market Share by Type (2020-2025)
Figure 32. North America Medical Second Opinion Revenue Market Share by Application (2020-2025)
Figure 33. Asia-Pacific Medical Second Opinion Revenue 2020-2031 (US$ Million)
Figure 34. Asia-Pacific Medical Second Opinion Revenue Market Share by Region (2020-2031)
Figure 35. Asia-Pacific Medical Second Opinion Revenue Market Share by Type (2020-2025)
Figure 36. Asia-Pacific Medical Second Opinion Revenue Market Share by Application (2020-2025)
Figure 37. Europe Medical Second Opinion Revenue Growth Rate 2020-2031 (US$ Million)
Figure 38. Europe Medical Second Opinion Revenue Market Share by Country (2020-2031)
Figure 39. Europe Medical Second Opinion Revenue Market Share by Type (2020-2025)
Figure 40. Europe Medical Second Opinion Revenue Market Share by Application (2020-2025)
Figure 41. Latin America Medical Second Opinion Revenue Growth Rate 2020-2031 (US$ Million)
Figure 42. Latin America Medical Second Opinion Revenue Market Share by Country (2020-2031)
Figure 43. Latin America Medical Second Opinion Revenue Market Share by Type (2020-2025)
Figure 44. Latin America Medical Second Opinion Revenue Market Share by Application (2020-2025)
Figure 45. Middle East and Africa Medical Second Opinion Revenue Growth Rate 2020-2031 (US$ Million)
Figure 46. Middle East and Africa Medical Second Opinion Revenue Market Share by Country (2020-2031)
Figure 47. Middle East and Africa Medical Second Opinion Revenue Market Share by Type (2020-2025)
Figure 48. Middle East and Africa Medical Second Opinion Revenue Market Share by Application (2020-2025)
Figure 49. Medical Second Opinion Supply Chain (Upstream and Downstream Market)
Figure 50. Global Production Market Share of Medical Second Opinion Raw Materials by Region in 2024
Figure 51. Medical Second Opinion Distribution Channels
Figure 52. Global Medical Second Opinion Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 53. Global Medical Second Opinion Percentage 2020-2031: Online Sales VS Offline Sales
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
